Tumor-infiltrating CD8 TRM are characterized by the higher clonality of T-cell receptor repertoires [7,13] and can efficiently kill autologous tumor cells in a major histocompatibility complex class I-dependent manner [6,14]. This evidence concerns the gene CD8A and neoplasm.